According to our hypothesis that AD-associated TOMM40 genetic variants cause microglial activation, plasma levels of cytokines and COX-2 are expected to be upregulated in AD patients carrying TOMM40 genetic variants. Here, TOMM40 is linked to Alzheimer disease.